Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation

Chiara Messina, Franco Locatelli, Edoardo Lanino, Cornelio Uderzo, Graziella Zacchello, Simone Cesaro, Marta Pillon, Cesare Perotti, Claudia Del Fante, Maura Faraci, Lucia Rivabella, Elisabetta Calore, Pietro De Stefano, Marco Zecca, Giovanna Giorgiani, Alessandra Brugiolo, Adriana Balduzzi, Giorgio Dini, Luigi Zanesco, Roberto Dall'Amico

Research output: Contribution to journalArticle

Abstract

This study aimed to ascertain whether extracorporeal photochemotherapy (ECP) is an effective treatment for paediatric patients with refractory graft-versus-host disease (GVHD). From January 1992 to December 2000, 77 children (median age 8.6 years) with either acute (n = 33) or chronic (n = 44) GVHD, resistant to conventional immunosuppressive therapy, were treated with ECP in four Italian paediatric hospitals. After ECP, acute GVHD involving skin, liver and gut responded completely in 76%, 60% and 75% of patients respectively. The 5-year overall survival was 69% for responding patients vs 12% for non-responders (P = 0.001). Among the 44 children with chronic GVHD, 15 (44%) showed a complete response and 10 (29%) a significant improvement after ECP. The 5-year overall survival was 96% for responders vs 58% for non-responders (P = 0.04). Our results suggest that ECP is an effective treatment that may be useful in paediatric patients with either acute or chronic GVHD who have failed to respond to standard immunosuppressive therapy.

Original languageEnglish
Pages (from-to)118-127
Number of pages10
JournalBritish Journal of Haematology
Volume122
Issue number1
DOIs
Publication statusPublished - Jul 2003

Keywords

  • Extracorporeal photochemotherapy (ECP)
  • Graft-versus-host disease (GVHD)
  • Haematopoietic stem cell transplantation

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation'. Together they form a unique fingerprint.

  • Cite this

    Messina, C., Locatelli, F., Lanino, E., Uderzo, C., Zacchello, G., Cesaro, S., Pillon, M., Perotti, C., Del Fante, C., Faraci, M., Rivabella, L., Calore, E., De Stefano, P., Zecca, M., Giorgiani, G., Brugiolo, A., Balduzzi, A., Dini, G., Zanesco, L., & Dall'Amico, R. (2003). Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation. British Journal of Haematology, 122(1), 118-127. https://doi.org/10.1046/j.1365-2141.2003.04401.x